Global Liposomes Market Insights and Forecast to 2027

SKU ID : QYR-18074762 | Publishing Date : 21-Apr-2021 | No. of pages : 114

Detailed TOC of Global Liposomes Market Insights and Forecast to 2027

1 Study Coverage
    1.1 Liposomes Product Introduction
    1.2 Market by Type
        1.2.1 Global Liposomes Market Size Growth Rate by Type
        1.4.2 Liposomal Doxorubicin
        1.4.3 Liposomal Amphoteracin B
        1.2.4 Liposomal Paclitaxel
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Liposomes Market Size Growth Rate by Application
        1.3.2 Fungal Infection Therapy
        1.3.3 Cancer & Tumor Therapy
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Liposomes Sales Estimates and Forecasts 2016-2027
    2.2 Global Liposomes Revenue Estimates and Forecasts 2016-2027
    2.3 Global Liposomes Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Liposomes Regions by Sales
        2.4.1 Global Top Liposomes Regions by Sales (2016-2021)
        2.4.2 Global Top Liposomes Regions by Sales (2022-2027)
    2.5 Global Top Liposomes Regions by Revenue
        2.5.1 Global Top Liposomes Regions by Revenue (2016-2021)
        2.5.2 Global Top Liposomes Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Liposomes Sales by Manufacturers
        3.1.1 Global Top Liposomes Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Liposomes Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Liposomes Sales in 2020
    3.2 Global Liposomes Revenue by Manufacturers
        3.2.1 Global Top Liposomes Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Liposomes Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Liposomes Revenue in 2020
    3.3 Global Liposomes Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Liposomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Liposomes Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Liposomes Sales by Type
        4.1.1 Global Liposomes Historical Sales by Type (2016-2021)
        4.1.2 Global Liposomes Forecasted Sales by Type (2022-2027)
        4.1.3 Global Liposomes Sales Market Share by Type (2016-2027)
    4.2 Global Liposomes Revenue by Type
        4.2.1 Global Liposomes Historical Revenue by Type (2016-2021)
        4.2.2 Global Liposomes Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Liposomes Revenue Market Share by Type (2016-2027)
    4.3 Global Liposomes Price by Type
        4.3.1 Global Liposomes Price by Type (2016-2021)
        4.3.2 Global Liposomes Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Liposomes Sales by Application
        5.1.1 Global Liposomes Historical Sales by Application (2016-2021)
        5.1.2 Global Liposomes Forecasted Sales by Application (2022-2027)
        5.1.3 Global Liposomes Sales Market Share by Application (2016-2027)
    5.2 Global Liposomes Revenue by Application
        5.2.1 Global Liposomes Historical Revenue by Application (2016-2021)
        5.2.2 Global Liposomes Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Liposomes Revenue Market Share by Application (2016-2027)
    5.3 Global Liposomes Price by Application
        5.3.1 Global Liposomes Price by Application (2016-2021)
        5.3.2 Global Liposomes Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Liposomes Market Size by Type
        6.1.1 North America Liposomes Sales by Type (2016-2027)
        6.1.2 North America Liposomes Revenue by Type (2016-2027)
    6.2 North America Liposomes Market Size by Application
        6.2.1 North America Liposomes Sales by Application (2016-2027)
        6.2.2 North America Liposomes Revenue by Application (2016-2027)
    6.3 North America Liposomes Market Size by Country
        6.3.1 North America Liposomes Sales by Country (2016-2027)
        6.3.2 North America Liposomes Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Liposomes Market Size by Type
        7.1.1 Europe Liposomes Sales by Type (2017-2027)
        7.1.2 Europe Liposomes Revenue by Type (2017-2027)
    7.2 Europe Liposomes Market Size by Application
        7.2.1 Europe Liposomes Sales by Application (2017-2027)
        7.2.2 Europe Liposomes Revenue by Application (2017-2027)
    7.3 Europe Liposomes Market Size by Country
        7.3.1 Europe Liposomes Sales by Country (2017-2027)
        7.3.2 Europe Liposomes Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Liposomes Market Size by Type
        8.1.1 Asia Pacific Liposomes Sales by Type (2018-2027)
        8.1.2 Asia Pacific Liposomes Revenue by Type (2018-2027)
    8.2 Asia Pacific Liposomes Market Size by Application
        8.2.1 Asia Pacific Liposomes Sales by Application (2018-2027)
        8.2.2 Asia Pacific Liposomes Revenue by Application (2018-2027)
    8.3 Asia Pacific Liposomes Market Size by Region
        8.3.1 Asia Pacific Liposomes Sales by Region (2018-2027)
        8.3.2 Asia Pacific Liposomes Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Liposomes Market Size by Type
        9.1.1 Latin America Liposomes Sales by Type (2019-2027)
        9.1.2 Latin America Liposomes Revenue by Type (2019-2027)
    9.2 Latin America Liposomes Market Size by Application
        9.2.1 Latin America Liposomes Sales by Application (2019-2027)
        9.2.2 Latin America Liposomes Revenue by Application (2019-2027)
    9.3 Latin America Liposomes Market Size by Country
        9.3.1 Latin America Liposomes Sales by Country (2019-2027)
        9.3.2 Latin America Liposomes Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Liposomes Market Size by Type
        6.1.1 Middle East and Africa Liposomes Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Liposomes Revenue by Type (2016-2027)
    6.2 Middle East and Africa Liposomes Market Size by Application
        6.2.1 Middle East and Africa Liposomes Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Liposomes Revenue by Application (2016-2027)
    6.3 Middle East and Africa Liposomes Market Size by Country
        6.3.1 Middle East and Africa Liposomes Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Liposomes Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Johnson & Johnson
        11.1.1 Johnson & Johnson Corporation Information
        11.1.2 Johnson & Johnson Overview
        11.1.3 Johnson & Johnson Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Johnson & Johnson Liposomes Product Description
        11.1.5 Johnson & Johnson Related Developments
    11.2 Gilead Sciences
        11.2.1 Gilead Sciences Corporation Information
        11.2.2 Gilead Sciences Overview
        11.2.3 Gilead Sciences Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Gilead Sciences Liposomes Product Description
        11.2.5 Gilead Sciences Related Developments
    11.3 Pacira
        11.3.1 Pacira Corporation Information
        11.3.2 Pacira Overview
        11.3.3 Pacira Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Pacira Liposomes Product Description
        11.3.5 Pacira Related Developments
    11.4 Sun Pharmaceutical
        11.4.1 Sun Pharmaceutical Corporation Information
        11.4.2 Sun Pharmaceutical Overview
        11.4.3 Sun Pharmaceutical Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Sun Pharmaceutical Liposomes Product Description
        11.4.5 Sun Pharmaceutical Related Developments
    11.5 Luye Pharma
        11.5.1 Luye Pharma Corporation Information
        11.5.2 Luye Pharma Overview
        11.5.3 Luye Pharma Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Luye Pharma Liposomes Product Description
        11.5.5 Luye Pharma Related Developments
    11.6 Sigma-Tau Group
        11.6.1 Sigma-Tau Group Corporation Information
        11.6.2 Sigma-Tau Group Overview
        11.6.3 Sigma-Tau Group Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Sigma-Tau Group Liposomes Product Description
        11.6.5 Sigma-Tau Group Related Developments
    11.7 Fudan-Zhangjiang
        11.7.1 Fudan-Zhangjiang Corporation Information
        11.7.2 Fudan-Zhangjiang Overview
        11.7.3 Fudan-Zhangjiang Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Fudan-Zhangjiang Liposomes Product Description
        11.7.5 Fudan-Zhangjiang Related Developments
    11.8 Teva Pharmaceutical
        11.8.1 Teva Pharmaceutical Corporation Information
        11.8.2 Teva Pharmaceutical Overview
        11.8.3 Teva Pharmaceutical Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Teva Pharmaceutical Liposomes Product Description
        11.8.5 Teva Pharmaceutical Related Developments
    11.9 CSPC
        11.9.1 CSPC Corporation Information
        11.9.2 CSPC Overview
        11.9.3 CSPC Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 CSPC Liposomes Product Description
        11.9.5 CSPC Related Developments
    11.10 Novartis
        11.10.1 Novartis Corporation Information
        11.10.2 Novartis Overview
        11.10.3 Novartis Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Novartis Liposomes Product Description
        11.10.5 Novartis Related Developments
    11.1 Johnson & Johnson
        11.1.1 Johnson & Johnson Corporation Information
        11.1.2 Johnson & Johnson Overview
        11.1.3 Johnson & Johnson Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Johnson & Johnson Liposomes Product Description
        11.1.5 Johnson & Johnson Related Developments
    11.12 Spectrum Pharmaceuticals
        11.12.1 Spectrum Pharmaceuticals Corporation Information
        11.12.2 Spectrum Pharmaceuticals Overview
        11.12.3 Spectrum Pharmaceuticals Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 Spectrum Pharmaceuticals Product Description
        11.12.5 Spectrum Pharmaceuticals Related Developments
    11.13 Shanghai New Asia
        11.13.1 Shanghai New Asia Corporation Information
        11.13.2 Shanghai New Asia Overview
        11.13.3 Shanghai New Asia Liposomes Sales, Price, Revenue and Gross Margin (2016-2021)
        11.13.4 Shanghai New Asia Product Description
        11.13.5 Shanghai New Asia Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Liposomes Value Chain Analysis
    12.2 Liposomes Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Liposomes Production Mode & Process
    12.4 Liposomes Sales and Marketing
        12.4.1 Liposomes Sales Channels
        12.4.2 Liposomes Distributors
    12.5 Liposomes Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Liposomes Industry Trends
    13.2 Liposomes Market Drivers
    13.3 Liposomes Market Challenges
    13.4 Liposomes Market Restraints

14 Key Findings in The Global Liposomes Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Figures, Tables and Charts Available in Global Liposomes Market Insights and Forecast to 2027

List of Tables
    Table 1. Global Liposomes Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Liposomal Doxorubicin
    Table 3. Major Manufacturers of Liposomal Amphoteracin B
    Table 4. Major Manufacturers of Liposomal Paclitaxel
    Table 5. Major Manufacturers of Other
    Table 6. Global Liposomes Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 7. Global Liposomes Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 8. Global Liposomes Sales by Region (2016-2021) & (K Units)
    Table 9. Global Liposomes Sales Market Share by Region (2016-2021)
    Table 10. Global Liposomes Sales by Region (2016-2021) & (K Units)
    Table 11. Global Liposomes Sales Market Share by Region (2022-2027)
    Table 12. Global Liposomes Revenue by Region (2016-2021) & (US$ Million)
    Table 13. Global Liposomes Revenue Market Share by Region (2016-2021)
    Table 14. Global Liposomes Revenue by Region (2022-2027) & (US$ Million)
    Table 15. Global Liposomes Revenue Market Share by Region (2022-2027)
    Table 16. Global Liposomes Sales by Manufacturers (2016-2021) & (K Units)
    Table 17. Global Liposomes Sales Share by Manufacturers (2016-2021)
    Table 18. Global Liposomes Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 19. Global Liposomes Revenue Share by Manufacturers (2016-2021)
    Table 20. Liposomes Price by Manufacturers 2016-2021 (USD/Unit)
    Table 21. Global Liposomes Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Liposomes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomes as of 2020)
    Table 23. Liposomes Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Liposomes Product Offered
    Table 25. Date of Manufacturers Enter into Liposomes Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Liposomes Sales by Type (2016-2021) & (K Units)
    Table 28. Global Liposomes Sales by Type (2022-2027) & (K Units)
    Table 29. Global Liposomes Sales Share by Type (2016-2021)
    Table 30. Global Liposomes Sales Share by Type (2022-2027)
    Table 31. Global Liposomes Revenue by Type (2016-2021) & (US$ Million)
    Table 32. Global Liposomes Revenue by Type (2022-2027) & (US$ Million)
    Table 33. Global Liposomes Revenue Share by Type (2016-2021)
    Table 34. Global Liposomes Revenue Share by Type (2022-2027)
    Table 35. Liposomes Price by Type (2016-2021) & (USD/Unit)
    Table 36. Global Liposomes Price Forecast by Type (2022-2027) & (USD/Unit)
    Table 37. Global Liposomes Sales by Application (2016-2021) & (K Units)
    Table 38. Global Liposomes Sales by Application (2022-2027) & (K Units)
    Table 39. Global Liposomes Sales Share by Application (2016-2021)
    Table 40. Global Liposomes Sales Share by Application (2022-2027)
    Table 41. Global Liposomes Revenue by Application (2016-2021) & (US$ Million)
    Table 42. Global Liposomes Revenue by Application (2022-2027) & (US$ Million)
    Table 43. Global Liposomes Revenue Share by Application (2016-2021)
    Table 44. Global Liposomes Revenue Share by Application (2022-2027)
    Table 45. Liposomes Price by Application (2016-2021) & (USD/Unit)
    Table 46. Global Liposomes Price Forecast by Application (2022-2027) & (USD/Unit)
    Table 47. North America Liposomes Sales by Type (2016-2021) & (K Units)
    Table 48. North America Liposomes Sales by Type (2022-2027) & (K Units)
    Table 49. North America Liposomes Revenue by Type (2016-2021) & (US$ Million)
    Table 50. North America Liposomes Revenue by Type (2022-2027) & (US$ Million)
    Table 51. North America Liposomes Sales by Application (2016-2021) & (K Units)
    Table 52. North America Liposomes Sales by Application (2022-2027) & (K Units)
    Table 53. North America Liposomes Revenue by Application (2016-2021) & (US$ Million)
    Table 54. North America Liposomes Revenue by Application (2022-2027) & (US$ Million)
    Table 55. North America Liposomes Sales by Country (2016-2021) & (K Units)
    Table 56. North America Liposomes Sales by Country (2022-2027) & (K Units)
    Table 57. North America Liposomes Revenue by Country (2016-2021) & (US$ Million)
    Table 58. North America Liposomes Revenue by Country (2022-2027) & (US$ Million)
    Table 59. Europe Liposomes Sales by Type (2016-2021) & (K Units)
    Table 60. Europe Liposomes Sales by Type (2022-2027) & (K Units)
    Table 61. Europe Liposomes Revenue by Type (2016-2021) & (US$ Million)
    Table 62. Europe Liposomes Revenue by Type (2022-2027) & (US$ Million)
    Table 63. Europe Liposomes Sales by Application (2016-2021) & (K Units)
    Table 64. Europe Liposomes Sales by Application (2022-2027) & (K Units)
    Table 65. Europe Liposomes Revenue by Application (2016-2021) & (US$ Million)
    Table 66. Europe Liposomes Revenue by Application (2022-2027) & (US$ Million)
    Table 67. Europe Liposomes Sales by Country (2016-2021) & (K Units)
    Table 68. Europe Liposomes Sales by Country (2022-2027) & (K Units)
    Table 69. Europe Liposomes Revenue by Country (2016-2021) & (US$ Million)
    Table 70. Europe Liposomes Revenue by Country (2022-2027) & (US$ Million)
    Table 71. Asia Pacific Liposomes Sales by Type (2016-2021) & (K Units)
    Table 72. Asia Pacific Liposomes Sales by Type (2022-2027) & (K Units)
    Table 73. Asia Pacific Liposomes Revenue by Type (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Liposomes Revenue by Type (2022-2027) & (US$ Million)
    Table 75. Asia Pacific Liposomes Sales by Application (2016-2021) & (K Units)
    Table 76. Asia Pacific Liposomes Sales by Application (2022-2027) & (K Units)
    Table 77. Asia Pacific Liposomes Revenue by Application (2016-2021) & (US$ Million)
    Table 78. Asia Pacific Liposomes Revenue by Application (2022-2027) & (US$ Million)
    Table 79. Asia Pacific Liposomes Sales by Region (2016-2021) & (K Units)
    Table 80. Asia Pacific Liposomes Sales by Region (2022-2027) & (K Units)
    Table 81. Asia Pacific Liposomes Revenue by Region (2016-2021) & (US$ Million)
    Table 82. Asia Pacific Liposomes Revenue by Region (2022-2027) & (US$ Million)
    Table 83. Latin America Liposomes Sales by Type (2016-2021) & (K Units)
    Table 84. Latin America Liposomes Sales by Type (2022-2027) & (K Units)
    Table 85. Latin America Liposomes Revenue by Type (2016-2021) & (US$ Million)
    Table 86. Latin America Liposomes Revenue by Type (2022-2027) & (US$ Million)
    Table 87. Latin America Liposomes Sales by Application (2016-2021) & (K Units)
    Table 88. Latin America Liposomes Sales by Application (2022-2027) & (K Units)
    Table 89. Latin America Liposomes Revenue by Application (2016-2021) & (US$ Million)
    Table 90. Latin America Liposomes Revenue by Application (2022-2027) & (US$ Million)
    Table 91. Latin America Liposomes Sales by Country (2016-2021) & (K Units)
    Table 92. Latin America Liposomes Sales by Country (2022-2027) & (K Units)
    Table 93. Latin America Liposomes Revenue by Country (2016-2021) & (US$ Million)
    Table 94. Latin America Liposomes Revenue by Country (2022-2027) & (US$ Million)
    Table 95. Middle East and Africa Liposomes Sales by Type (2016-2021) & (K Units)
    Table 96. Middle East and Africa Liposomes Sales by Type (2022-2027) & (K Units)
    Table 97. Middle East and Africa Liposomes Revenue by Type (2016-2021) & (US$ Million)
    Table 98. Middle East and Africa Liposomes Revenue by Type (2022-2027) & (US$ Million)
    Table 99. Middle East and Africa Liposomes Sales by Application (2016-2021) & (K Units)
    Table 100. Middle East and Africa Liposomes Sales by Application (2022-2027) & (K Units)
    Table 101. Middle East and Africa Liposomes Revenue by Application (2016-2021) & (US$ Million)
    Table 102. Middle East and Africa Liposomes Revenue by Application (2022-2027) & (US$ Million)
    Table 103. Middle East and Africa Liposomes Sales by Country (2016-2021) & (K Units)
    Table 104. Middle East and Africa Liposomes Sales by Country (2022-2027) & (K Units)
    Table 105. Middle East and Africa Liposomes Revenue by Country (2016-2021) & (US$ Million)
    Table 106. Middle East and Africa Liposomes Revenue by Country (2022-2027) & (US$ Million)
    Table 107. Johnson & Johnson Corporation Information
    Table 108. Johnson & Johnson Description and Major Businesses
    Table 109. Johnson & Johnson Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 110. Johnson & Johnson Liposomes Product
    Table 111. Johnson & Johnson Recent Developments
    Table 112. Gilead Sciences Corporation Information
    Table 113. Gilead Sciences Description and Major Businesses
    Table 114. Gilead Sciences Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 115. Gilead Sciences Liposomes Product
    Table 116. Gilead Sciences Recent Developments
    Table 117. Pacira Corporation Information
    Table 118. Pacira Description and Major Businesses
    Table 119. Pacira Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 120. Pacira Liposomes Product
    Table 121. Pacira Recent Developments
    Table 122. Sun Pharmaceutical Corporation Information
    Table 123. Sun Pharmaceutical Description and Major Businesses
    Table 124. Sun Pharmaceutical Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 125. Sun Pharmaceutical Liposomes Product
    Table 126. Sun Pharmaceutical Recent Developments
    Table 127. Luye Pharma Corporation Information
    Table 128. Luye Pharma Description and Major Businesses
    Table 129. Luye Pharma Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 130. Luye Pharma Liposomes Product
    Table 131. Luye Pharma Recent Developments
    Table 132. Sigma-Tau Group Corporation Information
    Table 133. Sigma-Tau Group Description and Major Businesses
    Table 134. Sigma-Tau Group Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 135. Sigma-Tau Group Liposomes Product
    Table 136. Sigma-Tau Group Recent Developments
    Table 137. Fudan-Zhangjiang Corporation Information
    Table 138. Fudan-Zhangjiang Description and Major Businesses
    Table 139. Fudan-Zhangjiang Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 140. Fudan-Zhangjiang Liposomes Product
    Table 141. Fudan-Zhangjiang Recent Developments
    Table 142. Teva Pharmaceutical Corporation Information
    Table 143. Teva Pharmaceutical Description and Major Businesses
    Table 144. Teva Pharmaceutical Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 145. Teva Pharmaceutical Liposomes Product
    Table 146. Teva Pharmaceutical Recent Developments
    Table 147. CSPC Corporation Information
    Table 148. CSPC Description and Major Businesses
    Table 149. CSPC Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 150. CSPC Liposomes Product
    Table 151. CSPC Recent Developments
    Table 152. Novartis Corporation Information
    Table 153. Novartis Description and Major Businesses
    Table 154. Novartis Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 155. Novartis Liposomes Product
    Table 156. Novartis Recent Developments
    Table 157. Kingond Pharm Corporation Information
    Table 158. Kingond Pharm Description and Major Businesses
    Table 159. Kingond Pharm Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 160. Kingond Pharm Liposomes Product
    Table 161. Kingond Pharm Recent Developments
    Table 162. Spectrum Pharmaceuticals Corporation Information
    Table 163. Spectrum Pharmaceuticals Description and Major Businesses
    Table 164. Spectrum Pharmaceuticals Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 165. Spectrum Pharmaceuticals Liposomes Product
    Table 166. Spectrum Pharmaceuticals Recent Developments
    Table 167. Shanghai New Asia Corporation Information
    Table 168. Shanghai New Asia Description and Major Businesses
    Table 169. Shanghai New Asia Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 170. Shanghai New Asia Liposomes Product
    Table 171. Shanghai New Asia Recent Developments
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Liposomes Distributors List
    Table 175. Liposomes Customers List
    Table 176. Liposomes Market Trends
    Table 177. Liposomes Market Drivers
    Table 178. Liposomes Market Challenges
    Table 179. Liposomes Market Restraints
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
List of Figures
    Figure 1. Liposomes Product Picture
    Figure 2. Global Liposomes Market Share by Type in 2020 & 2027
    Figure 3. Liposomal Doxorubicin Product Picture
    Figure 4. Liposomal Amphoteracin B Product Picture
    Figure 5. Liposomal Paclitaxel Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Liposomes Sales Market Share by Application in 2020 & 2027
    Figure 8. Fungal Infection Therapy
    Figure 9. Cancer & Tumor Therapy
    Figure 10. Other
    Figure 11. Liposomes Report Years Considered
    Figure 12. Global Liposomes Sales 2016-2027 (K Units)
    Figure 13. Global Liposomes Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Liposomes Revenue 2016-2027 (US$ Million)
    Figure 15. Global Liposomes Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 16. Global Liposomes Sales Market Share by Region (2016-2021)
    Figure 17. Global Liposomes Sales Market Share by Region (2022-2027)
    Figure 18. North America Liposomes Sales YoY (2016-2027) & (K Units)
    Figure 19. North America Liposomes Revenue YoY (2016-2027) & (US$ Million)
    Figure 20. Europe Liposomes Sales YoY (2016-2027) & (K Units)
    Figure 21. Europe Liposomes Revenue YoY (2016-2027) & (US$ Million)
    Figure 22. Asia-Pacific Liposomes Sales YoY (2016-2027) & (K Units)
    Figure 23. Asia-Pacific Liposomes Revenue YoY (2016-2027) & (US$ Million)
    Figure 24. Latin America Liposomes Sales YoY (2016-2027) & (K Units)
    Figure 25. Latin America Liposomes Revenue YoY (2016-2027) & (US$ Million)
    Figure 26. Middle East & Africa Liposomes Sales YoY (2016-2027) & (K Units)
    Figure 27. Middle East & Africa Liposomes Revenue YoY (2016-2027) & (US$ Million)
    Figure 28. The Top 10 and Top 5 Players Market Share by Liposomes Sales in 2020
    Figure 29. The Top 10 and Top 5 Players Market Share by Liposomes Revenue in 2020
    Figure 30. Liposomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 31. Global Liposomes Sales Market Share by Type (2016-2027)
    Figure 32. Global Liposomes Revenue Market Share by Type (2016-2027)
    Figure 33. Global Liposomes Sales Market Share by Application (2016-2027)
    Figure 34. Global Liposomes Revenue Market Share by Application (2016-2027)
    Figure 35. North America Liposomes Sales Market Share by Type (2016-2027)
    Figure 36. North America Liposomes Revenue Market Share by Type (2016-2027)
    Figure 37. North America Liposomes Sales Market Share by Application (2016-2027)
    Figure 38. North America Liposomes Revenue Market Share by Application (2016-2027)
    Figure 39. North America Liposomes Sales Share by Country (2016-2027)
    Figure 40. North America Liposomes Revenue Share by Country (2016-2027)
    Figure 41. U.S. Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 42. Canada Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 43. Europe Liposomes Sales Market Share by Type (2016-2027)
    Figure 44. Europe Liposomes Revenue Market Share by Type (2016-2027)
    Figure 45. Europe Liposomes Sales Market Share by Application (2016-2027)
    Figure 46. Europe Liposomes Revenue Market Share by Application (2016-2027)
    Figure 47. Europe Liposomes Sales Share by Country (2016-2027)
    Figure 48. Europe Liposomes Revenue Share by Country (2016-2027)
    Figure 49. Germany Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 50. France Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 51. U.K. Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 52. Italy Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 53. Russia Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 54. Asia Pacific Liposomes Sales Market Share by Type (2016-2027)
    Figure 55. Asia Pacific Liposomes Revenue Market Share by Type (2016-2027)
    Figure 56. Asia Pacific Liposomes Sales Market Share by Application (2016-2027)
    Figure 57. Asia Pacific Liposomes Revenue Market Share by Application (2016-2027)
    Figure 58. Asia Pacific Liposomes Sales Share by Region (2016-2027)
    Figure 59. Asia Pacific Liposomes Revenue Share by Region (2016-2027)
    Figure 60. China Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 61. Japan Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 62. South Korea Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 63. India Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 64. Australia Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 65. Taiwan Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 66. Indonesia Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 67. Thailand Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 68. Malaysia Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 69. Philippines Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 70. Latin America Liposomes Sales Market Share by Type (2016-2027)
    Figure 71. Latin America Liposomes Revenue Market Share by Type (2016-2027)
    Figure 72. Latin America Liposomes Sales Market Share by Application (2016-2027)
    Figure 73. Latin America Liposomes Revenue Market Share by Application (2016-2027)
    Figure 74. Latin America Liposomes Sales Share by Country (2016-2027)
    Figure 75. Latin America Liposomes Revenue Share by Country (2016-2027)
    Figure 76. Mexico Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 77. Brazil Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 78. Argentina Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 79. Middle East and Africa Liposomes Sales Market Share by Type (2016-2027)
    Figure 80. Middle East and Africa Liposomes Revenue Market Share by Type (2016-2027)
    Figure 81. Middle East and Africa Liposomes Sales Market Share by Application (2016-2027)
    Figure 82. Middle East and Africa Liposomes Revenue Market Share by Application (2016-2027)
    Figure 83. Middle East and Africa Liposomes Sales Share by Country (2016-2027)
    Figure 84. Middle East and Africa Liposomes Revenue Share by Country (2016-2027)
    Figure 85. Turkey Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 86. Saudi Arabia Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 87. U.A.E Liposomes Revenue (2016-2027) & (US$ Million)
    Figure 88. Liposomes Value Chain
    Figure 89. Liposomes Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed

Keyplayers in Global Liposomes Market Insights and Forecast to 2027

Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia